GeoVax Labs Inc. (GOVX) Financial Statements (2025 and earlier)

Company Profile

Business Address 1900 LAKE PARK DRIVE
SMYRNA, GA 30080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,45327,61311,4249,884283260
Cash and cash equivalents6,45327,61311,4249,884283260
Receivables      
Prepaid expense150155    
Other undisclosed current assets1,2831,171205351164360
Total current assets:7,88628,93911,62910,235447620
Noncurrent Assets
Property, plant and equipment2102351571481111
Other noncurrent assets1,1882,174    
Other undisclosed noncurrent assets   11111111
Total noncurrent assets:1,3972,4091681592222
TOTAL ASSETS:9,28331,34811,79710,394469642
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,5204,7485,4356272,0041,364
Accounts payable2,8031,7482,058268153126
Accrued liabilities7173,0003,3783591,8511,239
Debt    18313260
Total current liabilities:3,5204,7485,4358102,0161,625
Noncurrent Liabilities
Long-term debt and lease obligation    152740
Long-term debt, excluding current maturities    152740
Other undisclosed noncurrent liabilities   2,000   
Total noncurrent liabilities:   2,000152740
Total liabilities:3,5204,7487,4358252,0431,664
Equity
Equity, attributable to parent, including:5,76326,6004,3629,569(1,575)(1,022)
Preferred stock    761,932 
Common stock226640219
Additional paid in capital110,125104,97168,73155,29539,34037,264
Accumulated deficit(104,364)(78,397)(64,376)(45,806)(42,848)(40,477)
Other undisclosed equity, attributable to parent      1,971
Total equity:5,76326,6004,3629,569(1,575)(1,022)
TOTAL LIABILITIES AND EQUITY:9,28331,34811,79710,394469642

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues 823861,8241,176963
Gross profit: 823861,8241,176963
Operating expenses(26,743)(14,110)(19,131)(4,640)(3,548)(3,526)
Operating loss:(26,743)(14,029)(18,746)(2,817)(2,372)(2,563)
Nonoperating income (expense)7767176(141)23
Investment income, nonoperating77675265
Interest and debt expense  172(144)(4)(3)
Loss from continuing operations:(25,967)(14,021)(18,398)(3,102)(2,375)(2,563)
Loss before gain (loss) on sale of properties:(18,398)(3,102)(2,375)(2,563)
Net loss:(25,967)(14,021)(18,398)(3,102)(2,375)(2,563)
Other undisclosed net income (loss) attributable to parent  (172)14443
Net loss available to common stockholders, diluted:(25,967)(14,021)(18,570)(2,958)(2,371)(2,560)

Comprehensive Income ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(25,967)(14,021)(18,398)(3,102)(2,375)(2,563)
Comprehensive loss, net of tax, attributable to parent:(25,967)(14,021)(18,398)(3,102)(2,375)(2,563)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: